Pharmaceuticals | Page 3 | Citizens Against Government Waste

Pharmaceuticals

The WasteWatcher

Importation Will Not Lower Drug Costs

Citizens Against Government Waste (CAGW) was disappointed to see that the Trump Administration announced on Thursday, July 19, that the Food and Drug Administration (FDA) is exploring ways to import lower cost

Elizabeth Wright July 31, 2018
The WasteWatcher

President Trump’s Blueprint to Lower Drug Costs: A Lot to Unpack

On Friday, May 11, President Trump released his report on what his administration will do to lower drug costs.

Elizabeth Wright May 18, 2018
The WasteWatcher

President Trump's Drug Costs Proposals Coming Soon

The President has already made some good policy decisions and has offered other proposals that will help to lower drug costs.

Elizabeth Wright May 4, 2018
The WasteWatcher

Stealing Patents Won’t Bring Down Drug Costs

On February 15, 2018, 18 Democratic members of Congress sent a letter to Health and Human Services (HHS) Secretary Alex Azar, asking him to use his authority under 28 U.S.C.

Elizabeth Wright April 3, 2018
The WasteWatcher

Drug Prices - The Council of Economic Advisers and Trump Administration Weigh In

Last Friday, on February 9, 2018, the White House Council of Economic Advisers released a 30-page report on, “Reforming Biopharmaceutical Pricing at Home and Abroad.

Elizabeth Wright February 14, 2018
The WasteWatcher

Taxpayers and Patients Win First Round on 340B Drug Discount Rule

Citizens Against Government Waste (CAGW) discussed in its November 7, 2017 WasteWatcher blog, a Centers for Medicare and Medicaid Services (CMS) final rule for Medicare Part B that will lower costs to taxp

Elizabeth Wright January 5, 2018
The WasteWatcher

Rogue "Drug" Companies Face Congress

On Thursday, February 4, the House Committee on Oversight and Government Reform held a hearing entitled, “Developments in the Prescription Drug Market.”

Elizabeth Wright February 5, 2016
The WasteWatcher

Judge Tells Federal Agency to Obey the Law for Drug Discount Program

On October 14, the United States District Court for the District of Columbia struck down the Health Resources and Services Administration’s (HRSA) interpretive rule that ordered pharmaceutical manufacturers to provide substantial drug discounts...

Elizabeth Wright October 28, 2015
The WasteWatcher

More of the Same

Presidential candidate and former-Secretary of State Hillary Clinton proposed several worn-out initiatives this Tuesday that would supposedly lower drug prices but, if implemented, would seriously damage research and development in the United States...

Elizabeth Wright September 25, 2015
The WasteWatcher

Disappointing News on INNs from the FDA

You may recall I have written about the World Health Organization’s (WHO) naming system for drugs, called the International Non-Proprietary Name or INN, in a January 15, 2015 Swine Line

Elizabeth Wright September 15, 2015
The WasteWatcher

Howard Dean is Correct

It is not too often that I agree with former Vermont Governor and Democratic presidential candidate Howard Dean but when it comes to the government “negotiating” drug prices in Medicare Part D, he is correct.

Elizabeth Wright August 14, 2015
The WasteWatcher

More Proof the 340B Program Needs Reform

On July 6, the Government Accountability Office (GAO), the independent, non-partisan investigative arm of Congress, released a report entitled, “Medicare Part B Drugs: Action Needed to Reduce Financial Incentives to Prescribe 340B Drugs at Pa

Elizabeth Wright July 17, 2015

Pages

Sign Up For Email Updates


Optional Member Code